News Results

There are 645,912 News Results

Mar 18, 2024
enCore Energy Encounters Highest Grade Drill Results at Alta Mesa Uranium Project; Provides Status on South Texas Production Operations
NASDAQ:EU TSXV:EU www.encoreuranium.com
Mar 22, 2024
U.S. FDA Approves OPSYNVI® (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH)
OPSYNVI(®) combines two proven treatments with established efficacy and safety profiles into one tablet to be taken once daily, offering an option that helps to support the implementation of clinical...
Mar 27, 2024
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
--
Mar 27, 2024
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2023
TEL-AVIV, Israel, March 27, 2024 /PRNewswire/ --
Mar 28, 2024
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
TUCSON, Ariz., March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023. "In 2023, we made...
Apr 1, 2024
GSE Systems Reports Fourth Quarter and Fiscal 2023 Financial Results
Conference Call Scheduled for today, April 1, 2024 at 4:30pm ET
Apr 4, 2024
Johnson & Johnson to Showcase its Broad Scientific Leadership and Latest Innovations to Combat Cardiovascular Disease at ACC.24
Clinical and real-world evidence presentations highlight how the Company is transforming care for patients who are fighting some of the most common and devastating cardiovascular diseases
Apr 8, 2024
Findings Presented at ACC.24 Showed XARELTO® (rivaroxaban) Reduced the Risk of Clinically Significant Bleeding and Net Adverse Clinical Events or Rehospitalization
New exploratory analysis demonstrates consistent results of XARELTO(®) in treating elderly and non-elderly patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention
Apr 12, 2024
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results
Q2 Fiscal 2024 Highlights
Apr 15, 2024
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight
The emerging pipeline of CAR-T in NHL includes late-stage, mid-stage, and early-stage drugs in different lines of therapies and different indications, mainly including B- cell Lymphoma such as DLBCL, FL,...
64592

Pages

1

Stories of the day

Sep 12, 2025
DSEI 2025: Boxer – Rheinmetall increases capacity in Telford – with an eye on...
Sep 12, 2025
GA-ASI and AeroVironment Complete First-Ever Air Launch of Switchblade 600 from...
Sep 12, 2025
MBDA unveils STRATUS for future cruise and anti-ship capabilities
Sep 12, 2025
L3Harris Providing EO/IR targeting systems to Kongsberg Defence and Aerospace...